MYCN and neuroblastoma: We next searched the neuroblastoma immunopeptidomics dataset we created for peptides derived from the MYCN oncogene, a major cancer driver in neuroblastoma, finding only a single peptide (KATEYVHSL) presented on the relatively rare HLA-C*16:01 allele representing <5% of the population (Figure 3F).